  |
Investor Information
Thank you for your interest in Amarillo Biosciences Incorporated in 2005.
We are moving forward with interferon and additional cytokine products from our development programs.
We believe these products will prove to have the value to meet specific healthcare needs in the future.
From this page, you can view a copy of our annual and quarterly reports, link to NASDAQ and EDGAR web sites, access Amarillo press releases and view our company profile.
AMAR INVESTOR INFORMATION
1. Financials (10KSB/10QSB): Click here to link to Amarillo Biosciences at EDGAR, the SEC's on-line reporting database.2. Securities and Exchange Commission Filings: Click here to access a library of Amarillo Biosciences SEC filings.
View Filings from web site SEC Form 43. Current News: Click here to access a library of Amarillo Biosciences press releases.
4. About our Company: Click here for an expanded version of the Company Profile.
NOTE: If you are unable to view the above information and would like an investor information kit mailed to you, please contact us at..(806) 376-1741 or e-mail abi@amarbio.com. Your request will receive prompt attention.
If you need additional information not described on this page or in this site, please contact:
Dr. Joseph M. Cummins
President and CEO
4134 Business Park Drive
Amarillo, Texas 79110
Phone: (806) 376-1741
Fax: (806) 376-9301
jcummins@amarbio.com
|
- Amarillo Biosciences, Inc.
- 4134 Business Park Drive Amarillo, Texas 79110
- Phone: 806-376-1741 Fax: 806-376-9301 Amarbio.com